These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 2701778)

  • 21. Positron emission tomography in aging and dementia: effect of cerebral atrophy.
    Chawluk JB; Alavi A; Dann R; Hurtig HI; Bais S; Kushner MJ; Zimmerman RA; Reivich M
    J Nucl Med; 1987 Apr; 28(4):431-7. PubMed ID: 3494824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positron emission tomography.
    Cohen RM; Semple WE; Gross M
    Psychiatr Clin North Am; 1986 Mar; 9(1):63-79. PubMed ID: 3515332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Positron emission tomography in asphyxiated infants. Preliminary studies of regional cerebral glucose metabolism using 18F-FDG.
    Suhonen-Polvi H; Ruotsalainen U; Ahonen A; Haaparanta M; Aho K; Riikonen R; Kero P; Korvenranta H; Simell O; Wegelius U
    Acta Radiol Suppl; 1991; 376():173. PubMed ID: 1666770
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of cervical spinal cord stimulation (cSCS) on cerebral glucose metabolism and blood flow in a vegetative patient assessed by positron emission tomography (PET) and single photon emission computed tomography (SPECT).
    Momose T; Matsui T; Kosaka N; Ohtake T; Watanabe T; Nishikawa J; Abe K; Tanaka J; Takakura K; Iio M
    Radiat Med; 1989; 7(5):243-6. PubMed ID: 2629037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional brain imaging in 200 patients after whiplash injury.
    Otte A; Mueller-Brand J; Nitzsche EU; Wachter K; Ettlin TM
    J Nucl Med; 1997 Jun; 38(6):1002. PubMed ID: 9189162
    [No Abstract]   [Full Text] [Related]  

  • 26. PET: studies in dementia.
    Frackowiak RS
    Psychiatry Res; 1989 Sep; 29(3):353-5. PubMed ID: 2692056
    [No Abstract]   [Full Text] [Related]  

  • 27. The use and applications of single-photon emission computerised tomography in dementia.
    Geaney DP; Abou-Saleh MT
    Br J Psychiatry Suppl; 1990; (9):66-75. PubMed ID: 2291821
    [No Abstract]   [Full Text] [Related]  

  • 28. [Molecular imaging of cerebral blood flow and metabolism with SPET and PET in principal dementias].
    Gerasimou G; Bostantjopoulou S; Gotzamani-Psarrakou A
    Hell J Nucl Med; 2009; 12(1):79-83. PubMed ID: 19330195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography].
    M'Rabet N; Lotstra F; Goldman S; Delvenne V; Mendlewicz J
    Acta Psychiatr Belg; 1991; 91(6):311-26. PubMed ID: 1670424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of cerebrovascular disease with positron emission tomography: attempt of an in vivo model for treatment evaluation of brain glucose metabolism.
    Cinotti L; Croisile B; Laurent B; Le Bars D; Malbezin M; Mauguière F
    Eur Neurol; 1995; 35 Suppl 1():17-22. PubMed ID: 8529724
    [No Abstract]   [Full Text] [Related]  

  • 31. Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke.
    Silverman DH; Phelps ME
    Mol Genet Metab; 2001; 74(1-2):128-38. PubMed ID: 11592810
    [No Abstract]   [Full Text] [Related]  

  • 32. [Tomographic measurement of human cerebral glucose metabolism].
    Iwasaki Y; Konishi J; Makada Y; Yonekura Y
    Nihon Rinsho; 1991 Jul; 49(7):1528-31. PubMed ID: 1886247
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    Weinberger DR; Jones D; Reba RC; Mann U; Coppola R; Gibson R; Gorey J; Braun A; Chase TN
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):239-48. PubMed ID: 1498576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imaging human brain development with positron emission tomography.
    Chugani HT; Phelps ME
    J Nucl Med; 1991 Jan; 32(1):23-6. PubMed ID: 1988631
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of positron emission tomography in psychiatry].
    Degrell I; Berecz R; Glaub T; Lengyel Z; Egerházi A; Szakáll S; Trón L
    Orv Hetil; 2002 May; 143(21 Suppl 3):1311-4. PubMed ID: 12077925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simplified calculation of MRglc using PET.
    Phillips RL; London ED
    J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
    [No Abstract]   [Full Text] [Related]  

  • 37. Positron emission tomographic studies of regional cerebral glucose metabolism in idiopathic dystonia.
    Chase TN; Tamminga CA; Burrows H
    Adv Neurol; 1988; 50():237-41. PubMed ID: 3261115
    [No Abstract]   [Full Text] [Related]  

  • 38. Cerebral glucose utilization measured by positron emission tomography. [1-11C]-D-glucose compared with [2-18F]-2-fluoro-2-deoxy-D-glucose.
    Blomqvist G; Stone-Elander S; Halldin C; Roland PE; Swahn CG; Haaparanta M; Solin O; Lindqvist M; Widén L
    Acta Radiol Suppl; 1991; 376():171-2. PubMed ID: 1666769
    [No Abstract]   [Full Text] [Related]  

  • 39. Measurements of regional cerebral blood flow and metabolism in psychopathological states.
    Ingvar DH
    Eur Neurol; 1981; 20(3):294-6. PubMed ID: 6790285
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positron emission tomography in dementia.
    Ferris SH; de Leon MJ; Wolf AP; George AE; Reisberg B; Christman DR; Yonekura Y; Fowler JS
    Adv Neurol; 1983; 38():123-9. PubMed ID: 6604400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.